GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » Capex-to-Operating-Income

Anti-Microbialvior BioteQ Co (ROCO:6864) Capex-to-Operating-Income : 0.00 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Anti-Microbialvior BioteQ Co's Capital Expenditure for the six months ended in Dec. 2024 was NT$-3.50 Mil. Its Operating Income for the six months ended in Dec. 2024 was NT$-44.23 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Anti-Microbialvior BioteQ Co Capex-to-Operating-Income Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co Capex-to-Operating-Income Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income falls into.


;
;

Anti-Microbialvior BioteQ Co Capex-to-Operating-Income Calculation

Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-8.374) / -76.477
=N/A

Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-3.497) / -44.234
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anti-Microbialvior BioteQ Co  (ROCO:6864) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Anti-Microbialvior BioteQ Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Anti-Microbialvior BioteQ Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co Headlines

No Headlines